Whitehawk Therapeutics (WHWK) EBT Margin (2018 - 2025)
Historic EBT Margin for Whitehawk Therapeutics (WHWK) over the last 7 years, with Q1 2025 value amounting to 201.92%.
- Whitehawk Therapeutics' EBT Margin rose 1397200.0% to 201.92% in Q1 2025 from the same period last year, while for Sep 2025 it was 717.23%, marking a year-over-year decrease of 4711800.0%. This contributed to the annual value of 245.13% for FY2024, which is 249100.0% up from last year.
- Per Whitehawk Therapeutics' latest filing, its EBT Margin stood at 201.92% for Q1 2025, which was up 1397200.0% from 252.42% recorded in Q4 2024.
- Over the past 5 years, Whitehawk Therapeutics' EBT Margin peaked at 114.21% during Q4 2021, and registered a low of 4563.33% during Q1 2021.
- Its 5-year average for EBT Margin is 580.18%, with a median of 266.35% in 2022.
- Data for Whitehawk Therapeutics' EBT Margin shows a peak YoY increase of 39626800bps (in 2022) and a maximum YoY decrease of -1521300bps (in 2022) over the last 5 years.
- Over the past 5 years, Whitehawk Therapeutics' EBT Margin (Quarter) stood at 114.21% in 2021, then tumbled by -133bps to 266.35% in 2022, then increased by 3bps to 257.18% in 2023, then increased by 2bps to 252.42% in 2024, then increased by 20bps to 201.92% in 2025.
- Its EBT Margin was 201.92% in Q1 2025, compared to 252.42% in Q4 2024 and 173.95% in Q3 2024.